|Articles|February 15, 2007
Visiogen continues study of dual-optic IOL
Irvine, CA-Visiogen Inc. says it has received FDA approval to expand its phase III U.S. clinical trial for its dual-optic accommodating IOL (Synchrony).
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Metformin use associated with reduced incidence of intermediate AMD
2
MeiraGTx Licenses complement-targeted geographic atrophy program from ZipBio
3
Last year in glaucoma at EnVision Summit 2025
4
Looking back at the 2025 EnVision Summit
5
























